Fuster J, García-Valdecasas J C, Grande L, Tabet J, Bruix J, Anglada T, Taurá P, Lacy A M, González X, Vilana R, Bru C, Solé M, Visa J
Department of Surgery, Hospital Clinic, University of Barcelona, Spain.
Ann Surg. 1996 Mar;223(3):297-302. doi: 10.1097/00000658-199603000-00011.
The authors analyze the outcomes of patients with hepatocellular carcinoma (HCC) and cirrhosis who underwent liver resections.
Liver resection is the best option for HCC arising from hepatic cirrhosis. The experience of Western centers with these patients is shorter than the Asian series.
Forty-eight consecutive patients with cirrhosis and HCC who underwent liver resections were studied after a similar diagnostic and therapeutic process. Survival and cumulative recurrence were calculated according to pathologic findings.
Factors influencing survival at 3 years were as follows: type of resection, absence of vascular invasion, size of the tumor, absence of satellite nodules, and the number of nodules. Factors influencing the rate of recurrence at 3 years were the presence of vascular invasion and the presence of satellite nodules. Patients with favorable prognostic factors have a good survival rate with an acceptable recurrence rate.
Identification of prognostic factors may help in the selection of the appropriate treatment for these patients with HCC and cirrhosis.
作者分析接受肝切除术的肝细胞癌(HCC)合并肝硬化患者的预后。
肝切除术是肝硬化相关HCC的最佳治疗选择。西方中心处理这类患者的经验比亚洲系列报道的时间短。
对48例连续接受肝切除术的肝硬化合并HCC患者,在经过相似的诊断和治疗过程后进行研究。根据病理结果计算生存率和累积复发率。
影响3年生存率的因素如下:切除类型、无血管侵犯、肿瘤大小、无卫星结节以及结节数量。影响3年复发率的因素是血管侵犯的存在和卫星结节的存在。具有良好预后因素的患者生存率良好,复发率可接受。
识别预后因素可能有助于为这些HCC合并肝硬化患者选择合适的治疗方法。